FDA Reattempts Guidance On Third-Party 510(k) Review Program

FDA is again attempting to outline its thinking on the 510(k) third-party review program in a new draft guidance. The program, which allows accredited organizations to conduct 510(k) reviews for certain products, has had a lackluster performance since it was first mandated by Congress in 1997.

More from Regulation

More from Policy & Regulation